GoKawiilClosing the rare disease diagnostic gap can improve patient care and outcomes. Did you know that one in 10 Americans have a rare disease and it can take five or more years, on average, for a person with a rare disease to get an accurate diagnosis? That’s more than 30 million patients navigating long, costly, and uncertain diagnostic odysseys.
A genome-first multiomic approach to diagnosis
Why This Matters
This genome-first multiomic approach represents a significant advancement in diagnosing rare diseases, potentially reducing the time and cost associated with traditional diagnostic methods. For the tech industry, it highlights the growing importance of integrating genomics and multiomic data to improve healthcare outcomes for millions of patients. Consumers stand to benefit from faster, more accurate diagnoses, leading to better treatment options and quality of life.
Key Takeaways
- Accelerates diagnosis of rare diseases using multiomic data
- Reduces diagnostic time and costs for patients
- Highlights the role of advanced genomics in personalized medicine
Get alerts for these topics